Lentigen Technology Inc. (LTI)

https://www.lentigen.com

Lentigen Technology, Inc. (LTI; Gaithersburg, MD, US) is a wholly owned subsidiary of Miltenyi Biotech GmbH, and a leader in the design, construction and manufacture of Lentiviral vectors for clinical application. As a member of the Miltenyi Biotec family, a pioneer in developing innovative workflows, tools and technologies for clinical cell and gene therapy applications, LTI is dedicated to support customers to move from translational research into the clinic, and towards commercialization by complementing Miltenyi’s comprehensive portfolio of high quality, GMP compliant, state-of-the-art platforms and technologies. Miltenyi’s GMP manufacturing facilities in the U.S. and Germany meet both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) requirements for current Good Manufacturing Practices (cGMP). *

	Start	2014-08-14 reorganised
	Group	Miltenyi Biotec (Group)
	Predecessor	Lentigen Corporation
	Industry	lentiviral vector
	Person	Dropulic, Boro (Lentigen 200601 Founder + CEO)

	Region	Gaithersburg, MD
	Country	United States (USA)
	City	20878 Gaithersburg, MD
	Tel	+1-301-527-4200
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: TxCell S.A.. (6/19/17). "Press Release: TxCell Appoints Lentigen Technology, Inc. to Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection". Valbonne.

		Record changed: 2018-10-31